Search
Pharmaceutical Research Saarland (HIPS). Her research focuses on developing smart materials for controlled drug delivery – systems that adapt to their environment and release active compounds precisely where and
targets for therapeutic interventions. Her research provides a promising foundation for developing drugs to treat age-related diseases, particularly in the field of neurodegeneration. With the support of
bacteria that are capable of producing natural products that could potentially be developed into new drugs for infectious diseases. At the same time, the researchers are working on methods to gain unprecedented
methods and biotechnological production systems are being developed to harness their potential for drug research. Neilan's many years of expertise in the genetics, biosynthesis, and metabolic elucidation
Resistant strains of Mycobacterium tuberculosis are particularly problematic, as many established drugs are becoming increasingly ineffective against them. However, a research team from the Helmholtz Institute
Pulmonary drug delivery
Publication
Henning A,
Hein S,
Schneider M,
Bur M,
Lehr C
(2010)
Book, 197, 10.1007/978-3-642-00477-3_6
Book, 197, 10.1007/978-3-642-00477-3_6
pH-triggered drug release from biodegradable microwells for oral drug delivery
Publication
Nielsen L,
Nagstrup J,
Gordon S,
Keller S,
Østergaard J,
Rades T,
Müllertz A,
Boisen A
(2015)
Biomedical microdevices, 17, 3, 10.1007/s10544-015-9958-5, 25981751
Biomedical microdevices, 17, 3, 10.1007/s10544-015-9958-5, 25981751
Oral delivery of macromolecular drugs
Publication
Savla R,
Hartwig O,
Lim Chin W,
Loretz B,
Lehr C
(2018)
Pharm. Technol. Eur., 30, 7, 22-26
Pharm. Technol. Eur., 30, 7, 22-26